Quit Centre Quarterly Newsletter - December 2024
Read our summer edition of Quit Centre Quarterly.
NewsletterThe role of nurses in smoking cessation interventions for patients
A newly published review highlights the critical role nurses play in smoking cessation interventions. Analysis of 53 articles indicated that nurses commonly engaged in smoking assessment with patients, but it was not common for nurses to receive training in smoking cessation interventions. Smoking cessation training will enable nurses to deliver effective smoking cessation interventions with patients.
NewsHealth professional consultation survey
Your insights are important to us and the responses contribute to planning the future work of Quit Centre. We welcome participation and feedback from general practitioners, nurse practitioners, primary care nurses and pharmacists.
NewsNew training module: Pharmacists delivering nicotine dependence treatment under vaping reforms
The ‘Pharmacists delivering nicotine dependence treatment under vaping reforms’ online training module is designed to support pharmacists on the new regulatory framework introduced by the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024.
Vaping reforms
From 1 July 2024 the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Act 2024 has changed the way vapes can be sourced, supplied and advertised.
From 1 October 2024 pharmacists will be able to supply vapes with a nicotine concentration of 20 mg/mL or less, to people 18 years or over without a prescription subject to certain conditions and state and territory law.
NewsAustralian Prescriber article: Therapeutic vapes for smoking cessation and nicotine dependence
Quit Centre and Quit team members have authored this useful article, which has been published in December's Australian Prescriber.
Cytisine for cessation
A final decision has been made on proposed amendments to the Poisons Schedule in relation to cytisine. The delegate of the Secretary of the Department of Health and Aged Care (the Delegate) made the decision to create new entries for cytisine in Schedules 3 and 4 and Appendix H. Currently there are no cytisine products on the Australian Register of Therapeutic Goods. |
Quit Centre Quarterly Newsletter - September 2024
Read our spring issue of Quit Centre Quarterly.
NewsletterRACGP Guidelines - Supporting smoking & vaping cessation: A guide for health professionals
Guidance on smoking and vaping cessation support related to changes to Australia's vaping regulations, as of 1 October 2024.
NewsPharmaceutical Society of Australia – Professional practice guidelines: nicotine dependence support
The PSA has released new practice guidelines which provide advice to pharmacists when providing smoking cessation support.
News